report_lead_image_with_gradient.png
H1 2024

Healthcare Funds Report

Download this Report
To download this report, please complete the form below

This report was updated on September 5, 2024, to correct data points in the table on page 10.

Fill out the form to download a preview of this report. The full report is available through the PitchBook Platform.
Getting a checkup on 2024’s healthcare funds

Offering a guide to 481 healthcare and life sciences specialist managers across PE and VC, PitchBook’s H1 2024 Healthcare Funds Report provides a glimpse of these managers’ performance for the first half of 2024.

PE and VC’s fortunes are starting to diverge materially. PE healthcare specialists are outraising the broader asset class, with bigger fundraises and more frequent above target closes. Meanwhile, VC healthcare and life sciences fundraising declined as a proportion of overall VC fundraising. Moreover, as PE healthcare investing has become more competitive and complex in recent years, firms are becoming more operationally and thematically sophisticated.

As allocators continue to re-evaluate their alternatives allocations, PitchBook’s lead healthcare analyst Rebecca Springer breaks down capital formation within the sector.


Table of contents
Key takeaways 3
Introduction 4
Healthcare specialist PE fundraising trends 5
Healthcare specialist VC fundraising trends 8
Healthcare specialist performance 10
Spotlight: Healthcare PE firms differentiate amid growing competition 12
Manager lists 14
Inclusion criteria and categories 39